BMI and Weight Requirements for Joint Replacement Abroad

Every surgeon has a BMI threshold. Some are strict, some are flexible, and the number is never arbitrary.

If you have been told your BMI is too high for joint replacement at home, you may be wondering whether a surgeon abroad will operate at a higher BMI threshold. The answer is nuanced. Colombian orthopedic surgeons have BMI policies, but those policies vary by surgeon, by hospital, and by the specific joint and procedure. Understanding why the threshold exists, where it is set, and what you can do if you exceed it is essential before you invest in a consultation.

Why BMI matters for joint replacement

Elevated BMI increases the risk of surgical complications including wound infection (2 to 4 times higher above BMI 40), implant loosening (higher mechanical load on the prosthesis), anesthesia complications (difficult airway management, longer procedure time, higher doses of medications), venous thromboembolism (blood clots), and post-operative pneumonia. It also affects surgical outcomes: patients with BMI above 35 report less improvement in pain and function scores after knee replacement compared to patients with BMI below 30, though most still experience meaningful improvement.

Typical BMI thresholds

These are generalizations. Individual surgeons set their own thresholds based on their complication data, anesthesia team comfort, and the specific patient's distribution of weight and comorbidities. A patient with a BMI of 38 who is metabolically healthy (no diabetes, no sleep apnea, good cardiac fitness) may be accepted by a surgeon whose general threshold is 35. A patient with a BMI of 34 who has poorly controlled diabetes and severe sleep apnea may be declined by a surgeon whose threshold is 40.

What to do if you exceed the threshold

If your BMI exceeds the surgeon's threshold, you have three options. First, ask whether the threshold is a hard line or a guideline. Some surgeons will evaluate patients above their published threshold on a case-by-case basis, particularly if the patient's comorbidities are well controlled and they can demonstrate recent weight loss. Second, consider a pre-operative weight loss program. Losing 10 to 15 percent of body weight can bring many patients below the threshold and independently improves surgical outcomes and post-operative function. Some patients pursue GLP-1 medication-assisted weight loss for 3 to 6 months before rescheduling the joint replacement evaluation. Third, look for a surgeon or center that specializes in high-BMI joint replacement. These exist in the US (some academic centers have dedicated obese-arthroplasty programs) and abroad, though they are less common in medical tourism.

The GLP-1 pathway to qualification

Semaglutide (Wegovy) and tirzepatide (Zepbound) have changed the pre-operative optimization landscape for high-BMI patients. A 6-month course of GLP-1 medication typically produces 15 to 20 percent body weight loss, which can bring a patient from BMI 42 to BMI 35, crossing most surgical thresholds. The cost of the medication ($299 to $449 per month at current US manufacturer-direct pricing) spread over 6 months ($1,800 to $2,700 total) is a fraction of the cost of the joint replacement itself and produces a patient who is a better surgical candidate with lower complication risk and better expected outcomes.

If your BMI is above the surgical threshold and your orthopedist at home has recommended weight loss before surgery, consider starting the GLP-1 pathway now and scheduling the Colombian evaluation in 4 to 6 months. The imaging review and initial consultation can happen now; the surgery is scheduled after the weight target is reached.

The metabolic health distinction

BMI is a screening tool, not a comprehensive risk assessment. Two patients with identical BMIs can have dramatically different surgical risk profiles. A patient with BMI 38 who exercises regularly, has normal blood pressure, normal hemoglobin A1c, no sleep apnea, and no cardiac history is a fundamentally different surgical candidate than a patient with BMI 38 who is sedentary, has uncontrolled type 2 diabetes, uses a CPAP machine, and takes four blood pressure medications.

When your BMI is near the surgeon's threshold, the conversation should shift from the BMI number to the comorbidity profile. Provide the surgeon with your most recent hemoglobin A1c, blood pressure readings, sleep study results (if applicable), exercise capacity (can you walk a mile without stopping? Can you climb two flights of stairs?), and a complete medication list. A surgeon who declines based on BMI alone without reviewing metabolic health may be applying a policy rather than making a clinical judgment. A surgeon who reviews the full picture and still declines is making a decision you should take seriously.

What happens during surgery at higher BMI

Elevated BMI creates specific intra-operative challenges that are worth understanding. For the anesthesiologist, airway management is more difficult, drug dosing calculations are more complex (some medications are dosed on ideal body weight, others on actual body weight), and patient positioning requires additional equipment and staff. For the surgeon, deeper tissue planes mean longer incisions, more retraction, longer operating time, and reduced visibility. For the patient, these factors translate to higher infection risk (the single most consequential complication), higher risk of wound-healing problems, and longer anesthesia exposure.

These are not reasons to avoid surgery permanently. They are reasons to optimize your modifiable risk factors before scheduling. Every kilogram lost before surgery reduces the mechanical stress on the new joint, reduces the infection risk, and improves the anesthetic profile. The surgeon who recommends weight loss before operating is not gatekeeping; they are trying to give you the best possible outcome.